A Study of PLX2853 in Advanced Malignancies.
NCT03297424 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2022-07-25
Summary
The purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the investigational drug PLX2853 in subjects with advanced malignancies.
Conditions
Interventions
- DRUG
-
PLX2853
tablets
Sponsors & Collaborators
-
Opna Bio LLC
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-12
- Primary Completion
- 2021-06-07
- Completion
- 2021-06-07
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors
NCT02022982 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
NCT06270706 ·Status: RECRUITING ·Phase: PHASE1
-
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
NCT02452424 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
NCT00356941 ·Status: TERMINATED ·Phase: PHASE1
-
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
NCT02119650 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease
NCT01702714 ·Status: WITHDRAWN ·Phase: PHASE1
-
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
NCT02069158 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
NCT00974584 ·Status: COMPLETED ·Phase: PHASE1
-
Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC
NCT02504489 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
NCT02974725 ·Status: TERMINATED ·Phase: PHASE1
-
Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
NCT00082472 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.
NCT00238849 ·Status: UNKNOWN ·Phase: PHASE2
-
PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers
NCT04209595 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
NCT03836352 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC
NCT03912389 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
NCT00037817 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
NCT01493843 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer
NCT00145418 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Picoplatin Efficacy After Relapse
NCT00465491 ·Status: UNKNOWN ·Phase: PHASE3
-
A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer
NCT00723957 ·Status: COMPLETED ·Phase: PHASE2
-
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
NCT04902040 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
NCT00356122 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC
NCT00001450 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
NCT00534027 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
NCT00005032 ·Status: COMPLETED ·Phase: PHASE1/PHASE2